Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
A Model for CD8+ CTL Tumor Immunosurveillance and Regulation of Tumor Escape by CD4 T Cells Through an Effect on Quality of CTL
1999
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc
2008
Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine
1999
MYC on the Path to Cancer
2012 Standout
Global Cancer Statistics, 2002
2005 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Induction of cellular and humoral immune responses to tumor cells and peptides in HLA‐A24 positive hormone‐refractory prostate cancer patients by peptide vaccination
2003
Switching of self-assembly in a peptide nanostructure with a specific enzyme
2011
Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients
2007
Cancer Statistics, 2009
2009 Standout
Cushing's syndrome
2015 Standout
Cancer Statistics, 2008
2008 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells
2005
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma
2004
Immunology and immunotherapy of colorectal cancer
2003
Ipilimumab: Unleashing the Power of the Immune System Through CTLA-4 Blockade
2010
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
2003 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
2004
Protective and Damaging Effects of Stress Mediators
1998 Standout
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
2002
Cancer vaccines: between the idea and the reality
2003
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma.
1997
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses
1999
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma
2003
Cancer vaccines and carbohydrate epitopes
2011
Adjuvant therapy for high‐risk primary and resected metastatic melanoma
2003
Malignant Melanoma
1993
Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin
1999
Anti-Tyrosinase-Related Protein-2 Immune Response in Vitiligo Patients and Melanoma Patients Receiving Active-Specific Immunotherapy
1998
Renal clearance of quantum dots
2007 StandoutNobel
Cancer Statistics, 2010
2010 Standout
Nonfilamentous C. albicans Mutants Are Avirulent
1997 Standout
Vaccination of Women with Metastatic Breast Cancer, Using a Costimulatory Gene (CD80)-Modified, HLA-A2-Matched, Allogeneic, Breast Cancer Cell Line: Clinical and Immunological Results
2003
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
2004
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
2009
Immunotherapy for the Treatment of Urothelial Carcinoma
2016
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
2003
An Operational Near-Infrared Fluorescence Imaging System Prototype for Large Animal Surgery
2003
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
Bladder Cancer
2020 Standout
Adjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer With an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283
2000
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature
1981
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Melanoma and Vitiligo Are Associated With Antibody Responses to Similar Antigens on Pigment Cells
1995
The future of immune checkpoint therapy
2015 StandoutScienceNobel
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
2009
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
2017
Engineering InAsxP1-x/InP/ZnSe III−V Alloyed Core/Shell Quantum Dots for the Near-Infrared
2005 StandoutNobel
Multiple pathways to tumor immunity and concomitant autoimmunity
2002
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
2002
Proline Uptake in Candida albicans
1981
Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma
2003
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 Standout
The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy
1983
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity
2006 StandoutNobel
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Rishab K. Gupta being referenced
Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.
1975
Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model
1996
Androgen blockade enhances response to melanoma vaccine 1 1This work was supported in part by a Young Investigator Award from the American Society of Clinical Oncology (to Dr. Hsueh). Presented at the annual meeting of the American Society of Clinical Oncology, San Francisco, May 12–15, 2001.
2003
Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa
1993
Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine
1992
Active specific immunotherapy in malignant melanoma
1989
Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes
2002
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?
2000
Identification of a Natural Killer Enhancing Factor (NKEF) from Human Erythroid Cells
1993
CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer
2001
Successful transurethral intralesional BCG therapy of a bladder melanoma
1975
The Detection and Clinical Significance of Antibodies to Tumor-Associated Antigens in Patients with Renal Cell Carcinoma
1979
Autoantibody Cancer Biomarker: Extracellular Protein Kinase A
2006
Comparative Physiological Studies of the Yeast and Mycelial Forms of Histoplasma capsulatum : Uptake and Incorporation of l -Leucine
1971
Enhanced Humoral Immune Response Correlates With Improved Disease-Free and Overall Survival in American Joint Committee on Cancer Stage II Melanoma Patients Receiving Adjuvant Polyvalent Vaccine
2002
Human tumor cells grown in fetal calf serum and human serum: Influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects
1976
Humoral Immune Response to a Therapeutic Polyvalent Cancer Vaccine After Complete Resection of Thick Primary Melanoma and Sentinel Lymphadenectomy
2003